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Apoptosis and erythrocyte senescence share the common feature
of exposure of phosphatidylserine (PS) in the outer leaflet of the
cells. Western analysis showed that mature red cells contain Fas,
FasL, Fas-associated death domain (FADD), caspase 8, and caspase
3. Circulating, aged cells showed colocalization of Fas with the raft
marker proteins Gs and CD59; the existence of Fas-associated
FasL, FADD and caspase 8; and caspase 8 and caspase 3 activity.
Aged red cells had significantly lower aminophospholipid translo-
case activity and higher levels of PS externalization in comparison
with young cells. In support of our contention that caspases play a
functional role in the mature red cell, the oxidatively stressed red
cell recapitulated apoptotic events, including translocation of Fas
into rafts, formation of a Fas-associated complex, and activation of
caspases 8 and 3. These events were independent of calpain but
dependent on reactive oxygen species (ROS) as evident from the
effects of the ROS scavenger N-acetylcysteine. Caspase activation
was associated with loss of aminophospholipid translocase activity
andwith PS externalization. ROSwas not generated by treatment of
cells with t-butyl hydroperoxide at 10 °C, and Fas did not translo-
cate into rafts. Concomitantly, neither formation of a Fas-associ-
ated signaling complex nor caspase activation could be observed,
supporting the view that translocation of Fas into rafts was the trig-
ger for the chain of events leading to caspase 3 activation. Our data
demonstrate for the first time the novel involvement of Fas/caspase
8/caspase 3-dependent signaling in an enucleated cell leading to PS
externalization, a central feature of erythrophagocytosis and eryth-
rocyte biology.
Programmed cell death or apoptosis is a physiological process that
contributes to the homeostasis of multicellular organisms and main-
tains the balance between cell proliferation and cell death. The survival
of nucleated mammalian cells depends on the constant repression of
their self-destruction program by signals provided by other cells (1, 2).
Mature erythrocytes, like nucleated cells, share the capacity to self-
destruct at the end of a 120-day life span or in response to environmen-
tal signals. It is therefore likely that erythrocyte survival, lifespan, and
death are tightly regulated as in other cells. Whereas the process of
apoptosis has been studied in depth in nucleated cells, the role of apo-
ptotic regulatory molecules in enucleated cells such as platelets and
erythrocytes is poorly understood. Although the presence of aspartate
proteases has been documented for both cell types (3, 4), the function of
these proteases, if any, in red cell physiology is just beginning to be
appreciated.
The terminal steps of apoptosis in nucleated cells involve the proteo-
lytic activation of a family of aspartate-directed cysteine proteinases, the
best studied being the caspases. Activation of the effector caspases may
occur by the engagement of death receptors (5). In addition, most apop-
totic stimuli turn on a mitochondrion-dependent pathway (6–8).
Mature erythrocytes are terminally differentiated and lack mitochon-
dria as well as nucleus and other organelles. However, erythrocyte
senescence shares features common to apoptosis in nucleated cells,
such as the externalization of phosphatidylserine (PS)2 on the outer
leaflet of the cells. Erythrocytes were until recently considered to lack
pathways that have been traditionally linked to activation of the apop-
totic machinery in eukaryotic, nucleated cells. However, recent studies
have pointed in a direction indicating that part of the machinery that is
associated with execution of apoptosis in nucleated cells not only exists
in the mature human erythrocyte but is likely to be of physiological
significance. We have demonstrated that oxidative stress (9) and eryth-
rocyte aging (10) lead to stimulation of caspase 3 and caspase 3-medi-
ated degradation of band 3.
Apoptotic signaling pathways that lead to caspase 3 activation in
various cell types can be subdivided into twomajor categories: extrinsic
and intrinsic. In the extrinsic pathway, apoptotic signals are initiated by
cell surface death receptors exemplified by Fas, also known as CD95 or
APO-1, leading to the caspase 8-dependent activation of effector
caspases, such as caspase 3. Fas is widely expressed. Upon binding to
FasL, Fas recruits a cytosolic adapter protein, Fas-associated death
domain (FADD), which, in turn, recruits procaspase 8 and forms the
death-inducing signaling complex (DISC) (11, 12). Recruitment of pro-
caspase 8 to the DISC results in activation and release of active caspase
8, which directly activates caspase 3 and initiates cell death (13).
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Considering that erythrocytes lackmitochondria, yet undergo activa-
tion of aspartate-proteases such as caspases, we reasoned that amachin-
ery involving caspase 8 activation via death receptors prior to activation
of caspase 3 might exist in the mature erythrocyte. Our present studies
show that Fas, FasL, FADD, and caspase 8 localize to detergent-resistant
membrane microdomains of aged and oxidatively stressed red cells.
Concomitant with formation of this Fas-associated complex, aged or
oxidatively stressed red cells showed caspase 8 and caspase 3 activity, as
well as reduced aminophospholipid translocase (APLT) activity in com-
parison with young red cells. Our studies demonstrate unequivocally
that signaling pathways, culminating in activation of the prototypical
executioner caspase 3, play an essential role in PS externalization, a
central event linked to erythrophagocytosis.
EXPERIMENTAL PROCEDURES
Reagents—Anti-Fas and anti-caspase 8 rabbit polyclonal antibodies
were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Mouse
monoclonal antibody against Fas was from Upstate Biotechnology, Inc.
(Charlottesville, VA). Mouse monoclonal anti-FADD and anti-FasL
antibodieswere fromBDBiosciences. Rabbit polyclonal anti-FADDand
anti-caspase 3 antibodies were from Cell Signaling Technology (Bever-
ley, MA). Goat anti-rabbit Alexa 488 and goat anti-mouse Alexa 546
antibodies were fromMolecular Probes, Inc. (Eugene, OR). Annexin-V-
fluos was a product of Roche Applied Science. Anti-Gs antibody, t-bu-
tyl hydroperoxide (t-BHP), diamide, N-ethylmaleimide (NEM), phenyl
hydrazine (Ph-hyz)-HCl, horseradish peroxidase-conjugated goat anti-
rabbit antibody, methyl--cyclodextrin (MCD), and the fluorescent
probe dichlorofluorescein diacetate (DCFH-DA) were from Sigma.
Caspase 3 substrate Ac-DEVD-pNA, caspase 8 substrate, Ac-IETD-
AFC, caspase 3 inhibitor, Z-DEVD-FMK, caspase 8 inhibitor Z-IETD-
FMK, caspase 9 inhibitor Z-LEHD-FMK, calpain inhibitor calpeptin,
andN-acetylcysteine (NAC)were fromEMDBiosciences (La Jolla, CA).
Anti-CD59 antibody was from R & D Systems (Minneapolis, MN),
1-palmitoyl-2-[6-[7(nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-caproyl]-
sn-glycerol-3-phosphoserine (NBD-PS) was from Avanti Polar Lipids
(Birmingham, AL), and 3,3-dithiobis(sulfosuccinimidyl propionate)
(DTSSP) was from Pierce. All other reagents were of analytical grade.
Separation and Treatment of Red Blood Cells—Fresh blood was col-
lected from normal healthy volunteers with informed consent, and
packed erythrocytes were collected after centrifugation over a Ficoll
gradient. The erythrocytes were then washed three times in 25 mM
HEPES, pH 7.5, 150mMNaCl (buffer A) and diluted to 2% hematocrit in
the same buffer. Erythrocytes were treated for 15 min at 37 °C with
diamide, Ph-hyz, t-BHP, or NEM at the indicated concentrations.
Separation of Red Blood Cells on Percoll-Bovine Serum Albumin
(BSA) Gradients—Density-dependent separation of red cells was per-
formed as described byCorsi et al. (14)with slightmodifications. Briefly,
the plasma was removed, and erythrocytes were washed three times
with 10 mM sodium phosphate (pH 7.4), 150 mM NaCl, 5 mM glucose
(PBSG buffer) and layered at 25% hematocrit on a discontinuous Percoll
(55–85%, v/v)-BSA gradient followed by centrifugation at 1,500 g for
20 min at 20 °C. Young and aged erythrocytes were collected separately
and washed in PBSG buffer.
Measurement of Reactive Oxygen Species (ROS)—ROS produced
within erythrocytes were detected with the membrane-permeable
probe DCFH-DA. The probe freely enters the cell and is incorporated
into hydrophobic regions. The acetate moiety is cleaved off by cellular
esterases, leaving a nonfluorescent and impermeable form of DCFH
(15). ROS produced by cells oxidizes DCFH to fluorescent dichlorofluo-
rescein (DCF). Erythrocytes were incubated with 100 M DCFH-DA in
PBS for 30 min at 37 °C, prior to application of stress. Fluorescence was
monitored using an excitation wavelength of 485 nm and an emission
wavelength of 538 nm (16).
Western Blotting—Erythrocytes (2  108 cells) were usually lysed in
20 mM Tris-HCl, pH 7.5, containing 150 mM NaCl, 2 mM EDTA, 1%
Triton X-100, 10% glycerol, and protease inhibitors (20 g/ml leupep-
tin, 10g/ml pepstatin, 10g/ml aprotinin, and 1mM pefabloc) (buffer
B). Lysates were clarified, and proteins were separated on SDS-poly-
acrylamide gels and then transferred electrophoretically to polyvinyli-
dene difluoride membranes. The blots were blocked with 5% nonfat dry
milk and subsequently incubated overnight at 4 °C with primary anti-
bodies in Tris-buffered saline (TBS; 25 mM Tris, 150 mM NaCl, pH 7.4)
containing Tween 20 (1%, v/v) (TBST) and 5% (w/v) BSA. After wash-
ing, the blots were incubated with horseradish peroxidase-conjugated
goat anti-rabbit IgG (Cell Signaling Technology) (or appropriate sec-
ondary antibody) in blocking buffer for 1 h at room temperature, fol-
lowed by development with BM chemiluminescence reagent (Roche
Applied Science) and exposed to x-ray film (EastmanKodakCo. XAR5).
When performing Western blotting for detection of caspases, 6  105
cells were pelleted, freeze-thawed in 20 l of extraction buffer (50 mM
PIPES/NaOH, pH 6.5, 2 mM EDTA, 0.1% (w/v) CHAPS, 5 mM dithio-
threitol, and protease inhibitors). Rabbit polyclonal anti-FADD, anti-
FasL, anti-caspase 3, and anti-caspase 8 antibodies were used at a dilu-
tion of 1:1,000.
Immunoprecipitation—Erythrocytes (2  108 cells) were lysed in
buffer B for 15min at 4 °C. Lysates were centrifuged at 25,000 g for 15
min, and supernatants were immunoprecipitated overnight with rabbit
anti-Fas antibody (1:200) or anti-caspase 8 antibody (1:100) at 4 °C. The
supernatant was further incubated with 10 l of protein A/G-agarose
slurry for 3 h at 4 °C. Beads were pelleted, washed three time in lysis
buffer, and finally boiled in SDS gel denaturing buffer. Proteins were
separated by SDS-PAGE prior to Western blotting.
Fixation of Cells, Staining, and Confocal Microscopy—Treated and
untreated erythrocyteswere fixed in 95%methanol, 5% PBS for 5min on
glass slides. Cells were permeabilized further with 0.1% Triton X-100 in
the same fixative solution for 1 min. Blocking was done in PBS contain-
ing 3% BSA (PBSB) for 30 min at room temperature. Staining with
antibodies and washing of cells was done in PBSB. Mouse monoclonal
anti-Fas, rabbit polyclonal anti-caspase 8, and anti-Gs were used at a
dilution of 1:1,500 to stain the cells for 1 h at room temperature. Alexa
546-conjugated anti-mouse- and Alexa 488-conjugated anti-rabbit-
specific secondary antibodies were used at dilutions of 1:1,500 for 30
min at room temperature. After each staining, cells were washed thor-
oughly, and samples were mounted with glycerol/PBS (4:1) and
observed under a Zeiss LSM 510 confocal microscope.
Determination of Aminophospholipid Translocase Activity—Flippase
activity was assessed from the extent of fluorescent phospholipid
retained in the plasma membrane after back-extraction with BSA,
which extracts only exogenously added fluorescent phospholipids and
not endogenous phospholipids, from the outer monolayer (17). Briefly,
NBD-PS was reconstituted in 5 mMHEPES, pH 7.5, 14 mMNaCl, 5 mM
KCl, 1 mMMgCl2, and 10mM glucose (buffer C). The lipid was added to
a final concentration of 1 M to erythrocytes and incubated on ice for 5
min in buffer C, followed by incubation at 37 °C for 1 h. 100-l aliquots
were removed at different time intervals and added to 1ml of cold buffer
B containing 1% fatty acid-free BSA in order to extract NBD-PS present
in the outer leaflet. Fluorescence associated with the supernatant was
measured in a spectrofluorimeter at an excitationwavelength of 472 nm
and an emission wavelength of 534 nm.
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Determination of Annexin Binding to Red Cells—Labeling with
annexin-fluos was performed using the annexin-fluos kit from Roche
Applied Science according to the manufacturer’s instructions. Data
acquisitionwas performed on a BDBiosiences FACScaliber flow cytom-
eter, and analysis was done with Cell Quest software. 10,000 events/
sample were acquired to ensure adequatemean fluorescence levels. The
percentage of annexinV-positive erythrocyteswas determined from the
fluorescence signal in excess of that obtainedwith a negative (unlabeled)
control that was run in each case.
Isolation of Lipid Rafts from Erythrocyte Ghosts—Erythrocyte ghosts
were prepared from young, aged, or oxidatively stressed cells separated
on Percoll-BSA gradients as described above. Detergent-resistantmem-
brane (DRM) fractions were isolated from ghosts according to the
method of Samuel et al. (18) with some modifications. Briefly, ghosts
from 2 109 cells were extracted at 4 °C in 1.5 ml of TBS containing 1%
Triton X-100, protease inhibitors, and 1 mM EDTA and subjected to a
sucrose flotation gradient. After 30 min at 4 °C, the extract was mixed
with an equal volume of 80% (w/v) sucrose, overlaid with 30% (w/v)
sucrose and 5% sucrose, and subjected to ultracentrifugation in an
AH-629 rotor (Sorvall) at 27,000 rpm for 3 h at 4 °C. The top 4 ml was
collected as the first fraction. Proceeding down the gradient, fractions
2–6 were collected as 3-ml aliquots. Samples were precipitated with
chilled acetone, and 40 g of each protein sample was separated by
SDS-PAGE, followed by Western blotting with different antibodies.
Cholesterol Depletion of Erythrocytes—“Lipid rafts” are now widely
accepted as membrane microdomains enriched in sphingolipids and
cholesterol (19, 20). Cyclodextrins selectively extract cholesterol and
disrupt membrane rafts (21). Cholesterol depletion was accomplished
by treating erythrocytes (at 5% hematocrit) in PBS containing 3mMKCl
with 4mMMCD for 2 h at 37 °C (23). The erythrocyteswerewashedwith
PBS to remove MCD and associated cholesterol. Approximately 90% of
the total cholesterolwas removed by this process, since erythrocyte choles-
terol is almost entirely associated with the plasmamembrane.
Chemical Cross-linking byDTSSP—DTSSP is a water-soluble, imper-
meable, thiol-cleavable cross-linker. For cross-linking, 2 108 erythro-
cytes/ml were incubated with 1 mM DTSSP in PBS at 25 °C (24) for 30
min. The reaction mix was further incubated with 10 mM Tris-HCl for
15 min at 25 °C to terminate the cross-linking reaction. Cells were then
lysed in 1% Triton X-100, 5 mM iodoacetate, protease inhibitors, 150
mM NaCl, 15 mM EDTA, and 10 mM Tris-HCl. Lysates were immuno-
precipitated with anti-Fas antibody as described earlier. After immuno-
precipitation, samples were divided in two portions and boiled sepa-
rately in SDS gel denaturing sample buffer (reducing condition) and
-mercaptoethanol-free sample buffer (nonreducing condition). Sam-
ples were separated by 7.5% SDS-PAGE and probed with anti-Fas
antibody.
Caspase Activity Assays—For caspase 3 or caspase 8 activity assays,
each well of microtiter plates was coated overnight with 2 g of rabbit
FIGURE 1.Agingandoxidative stress activate caspase8andare associatedwith formationof a Fas-associated signaling complex inmaturehumanerythrocytes.Untreated
old (A and B) or young erythrocytes (A and B) or cells treated for 15min with t-BHP (2 mM) at 37 °C (A and B) or at 10 °C (B) or with Ph-hyz (2 mM) (A and B), diamide (2 mM) (B), or NEM
(2 mM) (B) were lysed and immunoprecipitated with anti-caspase 8 (A) or anti-Fas antibody (B). In separate experiments, cells were pretreated with NAC (10 mM) or Z-IETD-FMK (100
M) or calpeptin (20 M) for 30 min prior to treatment with t-BHP or Ph-hyz (A). The immunoprecipitates were separated by SDS-PAGE and blotted with anti-caspase 8 (A and B),
anti-FADD (B), or anti-FasL (B) antibody. Blots were reprobedwith anti-Fas antibody to ensure equal loading of the gels (B). The bands of pro-caspase 8 (54 kDa) and cleaved caspase
8 (43/41 kDa) have been indicated in A. C, young, old, and t-BHP-treated cells were either left untreated () or treated () with the thiol-cleavable cross-linker DTSSP as described
under “Experimental Procedures.” Cell lysates were separated by SDS-PAGE under reducing (R) and nonreducing (NR) conditions and immunoblotted with anti-Fas antibody. High
molecular weight species of preassociated Fas induced by DTSSPwere visible under NR conditions (upper blot) in the case of old cells (third lane) as well as t-BHP-treated cells (fourth
lane) but not in the case of cells that had not been treated with t-BHP (first lane). Blots are representative of the results obtained in three separate experiments.
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polyclonal caspase 3 or caspase 8 antibody in sodium carbonate/bicar-
bonate buffer, pH 9.6. After washing with TBST, wells were incubated
with TBST containing 3% BSA for 30 min for blocking. Cell-free lysates
(from 2 108 cells) were loaded in appropriate wells, incubated for 4 h
at room temperature, and washed, and DEVDase- or IETDase-depend-
ent protease activity was determined using the colorimetric substrate
Ac-DEVD-pNA or the fluorimetric substrate Ac-IETD-AFC, respec-
tively, at a concentration of 100M in 50mMHEPES, pH 7.4, containing
1% sucrose, 0.1% CHAPS, and 10 mM DTT. pNA release was deter-
mined spectrophotometrically at 405 nm. AFC release was measured in
a spectrofluorimeter using excitation and emission wavelengths of 360
and 530 nm, respectively.
Statistical Analysis—Data are represented as the means  S.D. of
separate experiments. Student’s t test was performed to test statistical
significance. A value of p 0.05 was considered statistically significant.
RESULTS
Activation of Caspase 8 in Old Red Cells—In normal density-depend-
ent methods of separation, the youngest red cells are the lightest,
whereas the aged cells are in the dense fractions (25). Despite some
controversy over the years, the dense fraction of circulating red cells is
widely accepted to be enriched in aged erythrocytes (26). Therefore, for
the purpose of this study, the dense fraction of red cells (density higher
than 1.1 g/ml) will be referred to as aged (or old) red cells, and the
fractionwith a density lower than 1.082 g/mlwill be referred to as young
red cells. Our previous observations had demonstrated that active
caspase 3 is present in old red cells, whereas it could not be detected in
young cells (10). Since erythrocytes are devoid of mitochondria, a mito-
chondria-independent pathway of caspase 3 activation appeared possi-
ble. We therefore considered the possibility that caspase 3 activation
could be preceded by formation of a DISC-like assembly involving a
death receptor, followed by caspase 8 activation. This was further
explored as a likelihood, since caspase 8 and the death receptor Fas have
been shown to play an important role in erythroid development (27).
The cleaved 43/41-kDa caspase 8 band could be detected by Western
blotting in old but not in young red cells (Fig. 1A). An activity assay using
the substrate Ac-IETD-AFC showed a 3–4-fold increase in proteolytic
activity in old cells compared with young cells over three independent
sets of experiments.
Association of Fas with FADD and Caspase 8—In order to analyze
whether caspase 8 activation is associated with formation of complexes
involving death receptors and death-linked adapter proteins, coimmu-
noprecipitation experiments were performed. Red cell lysates were
immunoprecipitated with anti-Fas antibody, followed byWestern blot-
ting either with anti-caspase 8 or with anti-FADD antibody. Both
caspase 8 and FADD were found in the immunoprecipitates from old
cells (Fig. 1B) but not from the young cells. In addition, FasL was also
found to associate with Fas in old cells (Fig. 1B). The association of
caspase 8 with Fas was further confirmed by confocal microscopy. Fas
was present in the plasma membrane, whereas caspase 8 displayed
punctate staining in the cytosol of young cells (Fig. 2A). However,
caspase 8 translocated to the membrane in old cells. Merging of the
images suggested that caspase 8 colocalizeswith Fas in patches observed
in old cells (Fig. 2B).
Clustering of Fas in Membrane Microdomains in Old Red Cells—Re-
distribution of Fas into plasma membrane rafts is one possible mecha-
nism for regulating the efficiency of Fas-mediated death signaling (28,
29). The death-inducing signaling complex is recruited into rafts during
Fas-induced apoptosis (24). DRM rafts have been demonstrated in the
mature human erythrocyte (18, 30) and shown to regulate erythrocyte
2-adrenergic receptor and guanine nucleotide-binding protein (Gs)-
dependent signaling (31). Considering that translocation of Fas into
lipid rafts generates death-inducing signaling platforms (32) and that
clusters of Fas were observable in old cells by confocal microscopy, we
asked the question whether Fas translocates into membrane rafts in the
aged red cell. The consistent localization of Gs in erythrocyte rafts is
documented (18, 30). Confocalmicroscopy showed that the Fas clusters
observed in old cells colocalized with Gs (Fig. 3A). However, no colo-
calization of Fas with Gs was observed in young cells (Fig. 3B). Further,
DRM lipid rafts were isolated by discontinuous sucrose density gradient
centrifugation (33). Fractions from the gradient were analyzed by SDS-
PAGE and Western blotting. The position of the raft-associated pro-
teins in the gradient was determined by the presence of Gs and the
glycosylphosphatidylinositol-anchored protein CD59, which were
enriched in the upper part of the sucrose gradient (fraction 2) with a
secondary localization at the bottom of the gradient (fraction 6) (Fig. 4),
in accordance with the observations of Samuel et al. (18) andMurphy et
al. (30), indicating a separation of lipid rafts from the Triton X-100-
soluble membranes (30). Using a specific anti-Fas antibody, we found
that Fas was localized in the bottom fraction of the gradient in
untreated, young red cells (Fig. 4B), whereas it was recruited into the top
(lightest) fractions in aged cells, where it cofractionated with the raft
markers Gs and CD59 (Fig. 4A). We also found that FasL, FADD, and
FIGURE 2. Association of Fas with caspase 8 as demonstrated by confocal micros-
copy. Young (A) and old (B) cells were incubated with anti-Fas and anti-caspase 8 (casp.
8) antibody. Cells werewashed and labeledwith Alexa 488-conjugated rabbit IgG (green
for caspase 8) and Alexa 546-conjugated mouse IgG (red for Fas) as described under
“Experimental Procedures.” Colocalization of Fas with caspase 8 upon merging (yellow
patches) was observed in the case of old (B) cells only. The results shown are represent-
ative of three different experiments.
FIGURE 3. Partitioning of Fas inmembrane rafts
as demonstrated by confocal microscopy. Old
cells (A), young cells (B), and cells treated with
t-BHP at 37 °C (C) or at 10 °C (D) were incubated
with antibodies against Fas and Gs. Cells were
washed and labeledby incubatingwithAlexa 546-
conjugated mouse IgG (red, Fas) or Alexa-conju-
gated 488-conjugated rabbit IgG (green, Gs).
Areas of colocalizationbetween Fas andGs (a raft
marker) in the merge panels (yellow) are observ-
able in A and C but not in B and D. The results
shown are representative of three different exper-
iments. In all the experiments, 70% of the total
cell population showed the same labeling pattern,
indicating similar localization of markers.
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procaspase 8were recruited in the same light fractions (as the raftmark-
ers) in aged cells (Fig. 4A). However, in our experimental system, it was
not possible to address the question whether Fas is recruited first into
the rafts, before recruitment of other death-inducingmolecules, as is the
case for anti-CD3-stimulated T cells (24). MCD-mediated cholesterol
depletion is known to disrupt lipid rafts. Incubation of aged erythrocytes
with MCD resulted in a randomization of the distribution of Fas,
FADD, caspase 8, and FasL and a shift to the heavier fractions (Fig. 4C).
This finding favored our notion that Fas, FADD, caspase 8, and FasL
localize to rafts in aged erythrocytes. Our results demonstrate that
events in the lifespan of the circulating erythrocyte trigger the move-
ment of these molecules into distinct microdomains in aged, red cells.
ROS in Aged Red Cells—Since ROS has been extensively documented
to be linked to death signaling in a variety of cell types (24), we investi-
gated whether ROS could be detected in aged red cells. The oxidation of
2,7-DCFH-DA has been used in many laboratories to detect cellular
radical generation.We used this approach tomeasure ROS in aged cells
by measuring DCF in aged cells by fluorimetry. A 3-fold increase in
ROS was observed in aged cells compared with young cells (Fig. 5A).
The Oxidatively Stressed Red Cell as a Model—Since aged red cells
represent the terminal state of themature erythrocyte in its lifespan and
are not amenable to manipulation, we needed a model to validate some
of our hypotheses. Considering that it appeared likely that ROS could be
playing a role, we chose the oxidatively stressed red cell as our model.
Treatment of cells with t-BHP (2 mM) or Ph-hyz (2 mM) led to an
increase in ROS production over untreated, young cells comparable
with that observed in aged cells (Fig. 5A). Our previous studies have
documented that t-BHP-treated red cells showed caspase 3 activation
(9). The caspase 3 activity observed in aged cells was also comparable
with that observed in t-BHP-treated cells (Fig. 5C). We therefore chose
t-BHP-treated red cells as our model for further studies aimed at deter-
mining the causal involvement of caspase 8 in caspase 3 activation in red
cells.
Caspase 8 Activation Is Upstream of Caspase 3 Activation in Oxida-
tively Stressed Red Cells—Western analyses showed the appearance of a
43/41-kDa band (Fig. 1A) in stressed but not in control cells, suggesting
that oxidative stress is associated with caspase 8 activation. IETDase
activitymeasured byAFC releasewas also consistentlymore than 5-fold
higher in oxidatively stressed cells compared with untreated cells (data
not shown). Pretreatment of cells with NAC or Z-IETD-FMK resulted
in abrogation of oxidative stress-induced caspase 8 (Fig. 1A). Since cal-
peptin had no effect on caspase 8 activation (Fig. 1A), the involvement of
calpain in oxidative stress-induced caspase 8 activationwas ruled out. In
order to investigate whether caspase 8 activates caspase 3 in oxidatively
stressed cells, cells were pretreated with cell-permeable caspase inhibi-
tors prior to t-BHP treatment and Western blotting to assess caspase 3
activation. Caspase 3 activation was inhibited specifically by the caspase
3- and caspase 8-specific inhibitors Z-DEVD-FMK and Z-IETD-FMK,
respectively, but not by the caspase 9 inhibitor Z-LEHD-FMK (Fig. 5B),
suggesting that caspase 8 was probably the upstream protease involved
in caspase 3 cleavage. Caspase 3 activity was also assayed using the
substrate Ac-DEVD-pNA. Inhibition of activity by Z-DEVD-FMK and
Z-IETD-FMK but not by Z-LEHD-FMK (Fig. 5D) corroborated the
observation that caspase 3 is activated in a caspase 8-dependentmanner
in oxidatively stressed cells. Considering that Ca2 influx has been
implicated in erythrocyte apoptosis (34), young cells were loaded with
CaCl2 and the ionophoreA23187 prior to assessing caspase 3 activation.
No increase in caspase 3 activity was observed byWestern blotting (Fig.
5B) or the DEVDase activity assay (Fig. 5C), suggesting that Ca2 does
not play a role in caspase activation. Calpeptin pretreatment did not
influence caspase 3 activation (Fig. 5, B and D), ruling out the involve-
ment of calpain in the signaling pathway leading to the activation of
caspase 3.
FADD, FasL, andCaspase 8Associate with Fas inOxidatively Stressed
Cells—In order to analyze whether caspase 8 activation is linked to
formation of a death receptor-associated complex, cells after treatment
were lysed, and lysates were immunoprecipitated with anti-Fas anti-
body. The immunoprecipitates were immunoblotted with anti-FADD
or anti-caspase 8 antibody. Both FADD and caspase 8 could be detected
in the immunoprecipitates of cells treatedwith t-BHPor Ph-hyz at 37 °C
(Fig. 1B), suggesting that a Fas-associated complex is formed following
exposure of red cells to agents generating ROS. This complex could not,
however, be detected in cells treated with the thiol-reactive reagents
diamide and NEM, suggesting that ROS generation was specifically
required for formation of the Fas-associated complex. FasL was also
recruited in this complex, as evidenced by the fact that it could be
coimmunoprecipitated with Fas. In harmony with these observations,
Fas, FasL, FADD, and procaspase 8 were recruited in the detergent-
resistant raft fractions, mirroring their distribution in aged cells
(Fig. 4D).
Oligomerization of Fas in Aged and in t-BHP-treated Cells—The
presence of proteins in rafts favors their self-association (35, 36). The
formation of higher order oligomers of Fas has been reported to be
associated with death signaling.We analyzed the oligomerization of Fas
by incubating red cells with the thiol-cleavable cross-linker DTSSP for
30 min. After terminating the cross-linking reaction, samples were
immunoprecipitated with anti-Fas antibody, separated by 7.5% SDS-
PAGE under reducing and nonreducing conditions, electrotransferred
onto polyvinylidene difluoride membranes, and immunoblotted with
anti-Fas antibody. High molecular mass bands (70–200 kDa) appeared
FIGURE 4. Association of lipid rafts with DISC
formation.Old cells (A), young cells (B), cholester-
ol-depleted old cells obtained after treatment
with MCD (C) as described under “Experimental
Procedures,” or t-BHP-treated cells (D) were
washed with PBS and lysed, and the cell-free
supernatants were subjected to sucrose density
gradient fractionation. Fractions 1–6 (top to bot-
tom) were collected as described. Proteins in each
fraction were resolved by SDS-PAGE and blotted
with antibodies against CD59, Gs, Fas, FADD,
caspase 8, and FasL, as indicated.
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in nonreducing gels in both aged and t-BHP-treated cells (Fig. 1C) but
not in untreated, young erythrocytes.
Functional Relevance of the Translocation of Fas into Rafts—To test
whether t-BHP-mediated ROS generation and Fas clustering is relevant
to the downstream activation of caspases, the effects of t-BHP were
examined at 10 °C. Fluorescence attributable toDCFproduction follow-
ing t-BHP treatment at 10 °C was comparable with that of normal cells
(data not shown). Taking into consideration that ROS generation at
10 °Cwas not significantly different from that of untreated cells and that
10 °C is below the transition temperature of the membrane (37), we
reasoned that cells exposed to t-BHP at 10 °C would not be able to
undergo translocation of Fas into rafts, thereby leading to loss of death-
inducing function. Colocalization of Fas with Gs was observed in cells
treated with t-BHP at 37 °C (Fig. 3C). However, at 10 °C, Fas did not
FIGURE 5. Reactive oxygen species and caspase activation are associated with impairment of aminophospholipid translocase and PS externalization in human erythro-
cytes. A, cells were left untreated or treatedwith NAC (10mM) followed by incubationwithout or with t-BHP or Ph-hyz as described in the legend to Fig. 1A. The ROS present in these
treated cells aswell as in untreatedold or young cellswasmeasured in a spectrofluorimeter using theprobeDCFH-DAasdescribedunder “Experimental Procedures” using excitation
and emissionwavelengths of 485 and 538nm, respectively. The results are expressed as -fold increase in comparisonwith the data obtained in the case of untreated young cells only.
Data shown are means  S.D. (n  5). *, p  0.001. B, erythrocytes were either left untreated or treated with NAC (10 mM) or Z-IETD-FMK (100 M) or Z-DEVD-FMK (100 M) or
Z-LEHD-FMK (100 M) or calpeptin (20 M) for 30 min followed by incubation with t-BHP. In separate experiments, erythrocytes were treated with CaCl2 (1 mM) and the ionophore
A23187 (2 M) at 37 °C. Lysates were immunoprecipitated with anti-caspase 3 antibody and analyzed for caspase 3 by Western blotting with the same antibody. The bands
attributable to the pro (32 kDa) and cleaved (20 and 10 kDa) forms of caspase 3 are indicated. This blot is representative of three independent experiments. C, erythrocytes were
treatedwith CaCl2 (1mM) and the ionophore A23187 (2M) or with t-BHP at 37 or 10 °C.D, erythrocytes were treatedwith calpeptin, NAC, Z-IETD-FMK, Z-DEVD-FMK, or Z-LEHD-FMK
as described in B, followed by incubation with t-BHP at 37 °C. For C and D, caspase 3 present in the lysates of treated cells or in the lysates of untreated old and young cells (C) was
captured onmicrotiter plates coated with anti-caspase 3 antibody. Ac-DEVD-pNA (100M) was added to each well, and the release of pNAwasmeasured spectrophotometrically at
405nm. Results represent themeanof five sets of determinations S.D. *,p 0.001;NS, nonsignificant (p 0.5). InC, comparisons havebeenmadewith respect to young, untreated
cells. InD, comparisons have beenmadewith respect to t-BHP-treated cells that had not been subjected to any prior treatment. E, cells were treatedwith calpeptin or Z-IETD-FMK or
Z-DEVD-FMK or NAC, followed by incubationwith t-BHP or Ph-hyz. In separate experiments, cells were treatedwith t-BHP orwith Ph-hyz alone. Untreated young and old cells as well
as the treated cells were used to measure flippase activity. The amount of BSA-extractable PS in the outer monolayer was followed spectrofluorimetrically as described under
“Experimental Procedures.” Thepercentageof flippase activity is expressed relative to flippase activity inuntreatedyoungcells (young,100). Results represent themeansS.D. of five
sets of determinations. *, p 0.001 in comparison with untreated, young cells. F, cells were treated with the indicated reagents as described in E, followed by treatment with t-BHP.
PS externalization was assessed by flow cytometry using annexin-fluos as described under “Experimental Procedures.” The percentage of annexin-bound cells is expressed relative
to that obtained after t-BHP treatment of cells (C, 100%). Untreated, young cells did not show any detectable annexin-fluos binding. Results represent the means S.D. of five sets
of determinations. *, p 0.001 in comparison with t-BHP-treated cells.
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colocalize with the raft marker Gs (Fig. 3D), consistent with the view
that the translocation of Fas into rafts was possibly a prerequisite for
formation of the Fas-associated complex, since FADD, caspase 8, and
FasL could not be coimmunoprecipitated with Fas in cells treated with
t-BHP at 10 °C (Fig. 1B). Caspase 3 activity was also not detectable in
these cells (Fig. 5C).
ROS and Active Caspases Regulate Aminophospholipid Translocase
Activity in Erythrocytes in t-BHP-treated Cells—Different phospholipid
classes are asymmetrically distributed over the two halves of the lipid
bilayer in erythrocytes (38). The choline phospholipids phosphatidyl-
choline and sphingomyelin are concentrated in the outer leaflet,
whereas the aminophospholipids, phosphatidylethanolamine, and
phosphatidylserine (PS) are enriched in the outer leaflet (39–42). Oxi-
dant-induced damage has been proposed to be the underlying mecha-
nism for loss of membrane PS asymmetry in erythrocytes observed in
diseases, such as sickle cell disease, thalassemia, and diabetes, as well as
in senescent erythrocytes (43–46). The ATP-dependent aminophos-
pholipid translocase transports PS and, to a lesser extent, phosphati-
dylethanolamine from the outer to the inner leaflet of the plasmamem-
brane against the concentration gradient, thereby compensating for any
escape of PS or phosphatidylethanolamine to the outer leaflet (47–49).
In contrast to the translocase, an ATP-dependent nonspecific outward
movement (“flop”) of phospholipids (50) and calcium-dependent non-
specific, bidirectional movement of phospholipids across the mem-
brane, termed scrambling (51, 52), also occur in the red cell. Impaired
APLT activity and/or increased scrambling of phospholipids may con-
tribute to loss of phospholipid asymmetry. Our own studies have dem-
onstrated that oxidant-induced damage in erythrocytes activates
caspase 3, which inhibits APLT, leading to PS externalization and sub-
sequent erythrophagocytosis (9). Increased ROS generation has also
been linked to impairment of APLT activity in sickle cell disease (53).
Taking these findings into consideration, we investigated whether oxi-
dant-induced ROS generation and caspase 8 activation could be directly
linked to APLT activity. APLT activity was significantly lower in cells
treatedwith t-BHPor Ph-hyz (Fig. 5E), comparedwith young, untreated
cells. The activity in aged cells was comparable with that of t-BHP-
treated cells (Fig. 5E). The inhibition of APLT activity of red cells by
t-BHP could be blocked in cells pretreated with NAC, the caspase 8
inhibitor Z-IETD-FMK, or the caspase 3 inhibitor Z-DEVD-FMK (Fig.
5E). Calpeptin could not block t-BHP-induced loss of APLT activity,
ruling out the involvement of calpain in the caspase-dependent inhibi-
tion of APLT. Concomitant with the loss of APLT activity, t-BHP-
treated cells and aged cells displayed comparable PS externalization
(Fig. 5F) as assessed by annexin binding. As expected, the proportion of
PS-exposing cells diminished when cells were pretreated with NAC,
Z-DEVD-FMK, or Z-IETD-FMK prior to exposure to t-BHP (Fig. 5F).
DISCUSSION
Until recently, the mature human erythrocyte was not considered to
share any of the stimulus-triggered death signaling pathways that are
associated with apoptosis in nucleated cells. However, although eryth-
rocytes lack nuclei andmitochondria, they undergo some of the changes
associated with apoptosis, such as membrane blebbing and exposure of
PS. In recent years, several studies have demonstrated that triggers such
as oxidative stress and osmotic shock lead to “apoptotic” features in the
mature red cell. Some studies have focused on Ca2-dependent pro-
cesses in erythrocyte death (54) and PS externalization (55). Our own
studies have demonstrated that oxidative stress is associated with
caspase 3-dependent impairment of APLT activity, leading to PS exter-
nalization and erythrophagocytosis (9), and that caspase 3 is activated in
aged erythrocytes (10). PS normally localizes to the inner leaflet of cell
membranes. It is widely recognized that exposure of PS on the outer
leaflet serves as a signal for removal of aged red cells from the circula-
tion. It is a feature that the aged, enucleated mature human erythrocyte
shares with nucleated cells undergoing apoptosis. PS-exposing red cell
populations are associated with diseases such as sickle cell anemia (56),
thalassemia (57–59), and chronic renal failure (60). PS-exposing red
cells found among the very high and very low density fractions of sickle
cells have been reported to share the feature of loss of APLT activity
(59). This was interpreted as evidence that mechanisms of PS exposure
that are dependent on loss of APLT activity can be activated both at
early stages of red cell maturation and during its life in the circulation.
We have therefore investigated the events probably contributing to PS
exposure in circulating, human red cells, extending our previous obser-
vations that caspase 3 was activated under oxidative stress in red cells,
that this was directly linked to impaired APLT activity (9), and that
denser human red cells had detectable caspase 3 activity (10), unlike the
lighter cells.
Although death receptors have been extensively studied in other cells,
their potential functions in erythroid cells have been investigated only
recently. Fas is expressed at most stages throughout the maturation of
the human erythroid cell, whereas FasL is expressed only by mature
erythroblasts (27). Under conditions of limiting erythropoietin, apopto-
sis of erythroid precursors is induced by activation of Fas mediated by
FasL. de Maria et al. (27) have shown that maturation of erythroid cells
is blocked by activation of the Fas/FasL system through caspase-de-
pendent cleavage of GATA-1. However, the role of death receptors and
caspases in the mature human erythrocyte remains an unexplored area.
Based on our observations of caspase 3 activation in themature red cells,
we pursued these investigations to explore whether this could occur in
a death receptor-dependent manner. The denser (aged) fractions of red
cells were found to harbor the cleaved form of caspase 8, strengthening
the notion that the death receptor Fas could be a possible upstream
player in this pathway. These views were supported by our observations
that both the adapter protein FADD and caspase 8 were coimmunopre-
cipitated with Fas in aged but not in young cells. Finally, in aged cells,
Fas, FasL, FADD, and caspase 8 were observed to localize in detergent-
resistant membrane microdomains. Disruption of rafts resulted in a
randomization of Fas, FasL, FADD, and caspase 8 distribution in old
cells.Membrane FasL and Fas have been reported to form supramolecu-
lar clusters preceding recruitment and activation of downstream signal-
ing components (61, 62). Whether the translocation of FasL and its
interaction with Fas is a prerequisite for formation of a signaling com-
plex and downstream events leading to caspase activation is open to
further investigation.
Oxidatively stressed red cells mirrored the aged cells in terms of asso-
ciation of Fas with FasL, FADD, and caspase 8 and their localization in
lipid rafts. These associations, as well as activation of caspases 8 and 3,
could be blocked by the ROS scavenger NAC, making it appear likely
that the ROS-induced association of Fas with rafts is a prerequisite for
formation of a signaling complex at the red cell membrane, leading to a
sequence of events culminating in caspase 3 activation.
While acknowledging that the Ca2-dependent phospholipid scram-
blase and the ATP-dependent floppase are among the effectors of
scrambled phospholipid distribution in general, we focused here on the
APLT activity, which we observed to be caspase-sensitive. It was signif-
icantly lower in old or oxidatively stressed cells compared with young
cells. Hermann and Devaux (63) have demonstrated that ATP enrich-
ment of the dense, aged red cell population could not cancel the differ-
ences in APLT activity between young and old cells. Connor et al. (25)
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have demonstrated that differences in ATP levels to the extent observed
between young and aged red cells separated by the density-dependent
method adopted by us do not contribute to alterations in APLT activity
(63). Taking these reports into consideration, it appeared unlikely that
the diminished APLT activity observed by us could be attributed to
diminished ATP levels. Intracellular Ca2 levels in young and in aged
cells separated by density gradient centrifugation have been reported to
be 8.4 and 31.2 nM, respectively (64).We also observed a 4-fold increase
in Ca2 levels in aged red cells compared with young cells (data not
shown). Bitbol et al. (65) have demonstrated that the inhibitory effect of
Ca2 on the APLT activity starts at a Ca2 concentration of 200 nM. It
therefore appeared unlikely that an increase in Ca2 to the extent
observed by us in aged cells could account for the difference in APLT
activity between young and old cells.
On the other hand, pretreatment of red cells with the caspase 8- or
caspase 3-specific inhibitors or with NAC prior to application of oxida-
tive stress blocked the stress-induced inhibition of APLT activity, lead-
ing to the conclusion that caspase 8-dependent caspase 3 activation
could negatively regulate APLT activity either through direct proteo-
lytic cleavage of the APLT or through an indirect modulatory role
involving intermediate regulators of the flippase.
We have provided several lines of evidence suggesting that Fas-de-
pendent signaling processes play a role in regulating PS externalization,
one of the signals for red cell clearance from the circulation, by down-
regulating APLT in a caspase-dependent manner. These experiments
provide the first evidence of a role of death receptor-dependent signal-
ing in themature enucleated erythrocyte. It can perhaps nowbe claimed
with some confidence that death signaling components that have an
established role in erythropoiesis are not merely bystanders that have
been transferred to themature human erythrocyte during development.
They play a distinct role, at least under certain conditions, in regulating
red cell survival.
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